ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up – Still a Buy?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares gapped up before the market opened on Monday. The stock had previously closed at $14.38, but opened at $15.16. ChronoScale Corporation Common Stock shares last traded at $14.28, with a volume of 12,966 shares changing hands.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CHRN shares. Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They set an “outperform” rating and a $32.00 price target on the stock. Compass Point started coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 price objective on the stock. Finally, Weiss Ratings downgraded shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, October 23rd. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, ChronoScale Corporation Common Stock has a consensus rating of “Hold” and an average price target of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The firm’s 50 day moving average is $18.62 and its 200-day moving average is $15.97. The stock has a market capitalization of $2.08 billion, a price-to-earnings ratio of -3.30 and a beta of 0.98. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Wednesday, October 14th. The company reported ($0.29) EPS for the quarter. The company had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. Analysts forecast that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.